切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Topoisomerases

16件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  3. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  4. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  5. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  6. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  7. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  8. Ofloxacin
    A5511 Ofloxacin
    中文名: 氧氟沙星
    Target: Topoisomerases|DNA gyrase
    Summary: 氟喹诺酮类抗生素
      ≥12.03 mg/mL
      insoluble in H2O
  9. Dexrazoxane HCl (ICRF-187, ADR-529)
    A1602 Dexrazoxane HCl (ICRF-187, ADR-529)
    中文名: 右雷佐生盐酸盐
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,细胞内离子螯合剂,心脏保护剂
      ≥15.24 mg/mL
      ≥16 mg/mL
  10. Epirubicin HCl
    A2451 Epirubicin HCl
    中文名: 盐酸表阿霉素
    Target: Topoisomerases
    Summary: 抗生素类抗肿瘤药物
      ≥29.00 mg/mL
      ≥40.33 mg/mL

16件产品中的 1-10

页面
每页